Joshua Levy

Joshua Levy is the former U.S. Attorney for the District of Massachusetts. He has managed several clients through crisis situations and has three decades of experience both defending and prosecuting high-stakes health care fraud and white-collar cases. Josh, a fellow in the American College of Trial Lawyers, has been on the front lines for key clients facing government enforcement efforts since 2025, including Harvard University and Boston Children’s Hospital.

Josh, who returned to Ropes & Gray in 2025, supervised approximately 125 federal prosecutors as U.S. Attorney and was responsible for the investigation and prosecution of cases involving health care fraud, securities fraud, False Claims Act violations, national security matters and public corruption violations, among other criminal offenses. Josh assisted with developing DOJ’s corporate fraud policies as a member of the Deputy Attorney General's Corporate Crime Advisory Group. He also served on White Collar Crime and the Terrorism and National Security subcommittees of Attorney General Merrick Garland's Advisory Committee.

As a Ropes & Gray partner for nearly two decades before his most recent government service, Josh defended corporate and individual clients in several high-stakes DOJ and state Attorneys General investigations. Josh was lead counsel on two criminal jury trials against DOJ that resulted in the exoneration of the firm’s clients. Josh has also litigated numerous False Claims Act cases in federal district courts and Courts of Appeals.

Josh has also served in numerous management roles at Ropes & Gray, including as co-chair of the 325-lawyer litigation & enforcement practice and co-managing partner of the firm's Boston office.

Earlier in his career, Josh spent seven years as an Assistant U.S. Attorney in the U.S. Attorney’s Office for the District of Massachusetts, prosecuting a wide range of white-collar crimes. During that tenure, Josh received the prestigious U.S. Attorney General's Award for Exceptional Service for his work on a ground-breaking health care fraud prosecution.